pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ultragenyx Pharmaceutical Inc. ($RARE) · news · pharmadog
← back to Ultragenyx Pharmaceutical Inc.
News mentioning $RARE
837
stories
May 18, 26
Opinion: How to restore credibility to the CDC’s vaccine advisory committee
stat
May 17, 26
In Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected cases
stat
May 17, 26
STAT+: The hantavirus outbreak is prompting Covid flashbacks — including the conspiracies
stat
May 16, 26
Opinion: Marty Makary misunderstood something fundamental about the FDA
stat
May 15, 26
STAT+: FDA leadership shakeup widens following Makary’s departure
stat
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 15, 26
Opinion: First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
stat
May 15, 26
Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset
endpoints
May 15, 26
A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recorded
stat
May 15, 26
STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
stat
May 14, 26
Makary’s departure and Cassidy’s tenuous Senate seat
stat
May 14, 26
Imaging Clues That Raise Suspicion for Diffuse Midline Glioma
onclive
May 14, 26
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
biopharma dive
May 14, 26
Five-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase 3 trial (CT029)
onclive
May 14, 26
Regenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval
endpoints
May 14, 26
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
stat
May 14, 26
BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
endpoints
May 13, 26
Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?
stat
May 13, 26
Opinion: Hospitals are silencing doctors online, and it’s fueling the health misinformation crisis
stat
May 13, 26
STAT+: What the Trump administration wants in its next FDA leader
stat
May 13, 26
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
biopharma dive
May 13, 26
Abeona pivots to T cells; AstraZeneca's rare disease drug passes Phase 3
endpoints
May 13, 26
STAT+: Gene therapy viruses linked to a boy’s tumor
stat
May 13, 26
STAT+: Drug meant to make gene therapy safer may also make it less effective
stat
May 13, 26
STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding
stat
May 12, 26
STAT+: Why Marty Makary was the worst FDA commissioner in 25 years
stat
May 12, 26
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
biopharma dive
May 12, 26
STAT+: European Union inks a draft deal to boost local production of medicines and avoid shortages
stat
May 12, 26
STAT+: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in
stat
May 12, 26
Supreme Court extends mifepristone deadline
stat
← prev
page 25 of 28
next →
